Democrats want to keep Obamacare going. Republicans want to replace it, ideally with health savings accounts. Regardless of which approach holds sway this week—or whenever—either one would be woefully shortsighted. 

When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.

Physicians love AI scribes. Has anyone thought to ask patients what they think?

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

The director of the National Institutes of Health and his principal deputy are touting their success at ‘curing’ the agency of its self-inflicted DEI disability. 

Three out of four TTEs are being ordered by clinicians who are not cardiologists. Could this be having a negative impact on patient care?

State-level regulation of AI: President Trump has turned his thinking into action.